Abstract
Multinational companies (MNCs) exert influence over the rate of commercialization and corporatization of health care worldwide, through direct investment and through their influence on regulatory decision-making. However, multinational health care companies have shown an uneven process of expansion in the last five years in what they perceive as risky and highly politicized markets. Health policy needs to be informed by a good understanding of MNCs’ strategies of market development and regulatory influence.
“Health care is one the the most difficult markets to penetrate.”1
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Copyright information
© 2005 United Nations Research Institute for Social Development
About this chapter
Cite this chapter
Lethbridge, J. (2005). Strategies of Multinational Health Care Companies in Europe and Asia. In: Mackintosh, M., Koivusalo, M. (eds) Commercialization of Health Care. Social Policy in a Development Context. Palgrave Macmillan, London. https://doi.org/10.1057/9780230523616_2
Download citation
DOI: https://doi.org/10.1057/9780230523616_2
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-52212-5
Online ISBN: 978-0-230-52361-6
eBook Packages: Palgrave Economics & Finance CollectionEconomics and Finance (R0)